A Multi-Center, Double-Masked Study of the Safety and Efficacy of Travoprost APS Compared to TRAVATAN® in Patients with Open-Angle Glaucoma or Ocular Hypertension

Mise à jour : Il y a 4 ans
Référence : EUCTR2008-002760-34

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

To compare the efficacy and safety of Travoprost APS to TRAVATAN both dosed once-daily in the evening, in patients with open-angle glaucoma or ocular hypertension


Critère d'inclusion

  • open-angle glaucoma or ocular hypertension